Collectively, these data implicate NOX2 upregulation in driving oxidative stress and endothelial apoptosis at the BII in diabetes, while pharmacologic NOX2 blockade mitigates ROS accumulation and cell death. The gene discussed is CYBB; the disease is diabetes mellitus.